trimetazidine has been researched along with Coronary Disease in 61 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (24.59) | 18.7374 |
| 1990's | 19 (31.15) | 18.2507 |
| 2000's | 18 (29.51) | 29.6817 |
| 2010's | 3 (4.92) | 24.3611 |
| 2020's | 6 (9.84) | 2.80 |
| Authors | Studies |
|---|---|
| Li, N; Liu, J; Qiu, L; Shen, L; Shu, H; Zhou, N | 1 |
| Jin, YH; Liu, F; Lu, JC; Xiao, B; Yang, XC; Yin, PF | 1 |
| Lu, Y; Ni, H; Shi, H; Sun, Y; Wang, F | 1 |
| Herold, Z; Nagy, VL | 1 |
| Duan, Y; Lin, Y; Sun, ZQ; Wang, ZL; Yan, M; Zhu, FY | 1 |
| Abbasi, H; Alasadi, L; Amoozgar, B; Heshmatzadeh Behzadi, A; Jain, S; Prince, MR; Velasco, N; Zahid, U | 1 |
| Chen, F; Jin, Y; Liu, F; Lu, J; Xiao, B; Yang, X; Zhang, J | 1 |
| Gao, F; Liu, Y; Ma, H; Ma, Q; Shen, H; Shi, D; Wang, Z; Xu, X; Yu, M; Zhang, J; Zhang, W; Zhao, Y; Zhou, Y; Zhou, Z | 1 |
| Ermolenko, AA; Statsenko, ME; Turkina, SV | 1 |
| Białoszyński, T; Grabczewska, Z; Grześk, G; Kochman, W; Koziński, M; Kubica, J; Sukiennik, A; Swiatkiewicz, I; Szymański, P | 1 |
| Baksheev, VI; Kolomoets, NM; Uvaĭsova, KU | 1 |
| Caminiti, G; Fini, M; Gebara, O; Marazzi, G; Ramires, JA; Rosano, G; Vitale, C; Volterrani, M; Wajngarten, M | 1 |
| Gil Polo, B; Maicas Bellido, C; Rodríguez Padial, L; Velázquez Martín, M | 1 |
| Dogan, A; Okudan, B; Ozbek, FM; Ozturk, B; Yildiz, M | 1 |
| Altekin, E; Goldeli, O; Kuralay, F; Onvural, B; Yazlar, AS | 1 |
| Aksoy, Y; Akturk, E; Barutcu, I; Cehreli, S; Ozdemir, R; Sincer, I; Topal, E | 1 |
| Fragasso, G; Rosano, GM; Vitale, C | 1 |
| Belardinelli, R; Faccenda, E; Lacalaprice, F; Volpe, L | 1 |
| Celik, T; Iyisoy, A; Jata, B; Kursaklioglu, H | 1 |
| Marazzi, G; Rosano, GM; Volterrani, M | 1 |
| Levy, S | 1 |
| Buck, T; Kober, G; Pennaforte, S; Sievert, H; Vallbracht, C | 1 |
| Iliceto, S; Marangelli, V; Rizzon, P | 1 |
| Akgul, F; Batyraliev, TA; Birand, A; Kudaiberdieva, GZ; Usal, A | 1 |
| Anversa, P; Baldini, A; Kajstura, J; Leri, A; Li, B; Liu, Y; Olivetti, G | 1 |
| Chierchia, SL; Dabrowski, P; Fragasso, G; Lu, C | 1 |
| Barbarich, VB; Iakovlev, AV; Kuimov, AD; Luksha, EB; Maianskaia, SD; Poliakova, AM; Shliakhov, SO; Volkova, II | 1 |
| Allal, J; Harpey, C; Ourbak, P; Pornin, M; Sellier, P | 1 |
| McClellan, KJ; Plosker, GL | 1 |
| Cuocolo, A; De Rimini, ML; Florimonte, L; Golia, R; Mansi, L; Miletto, P; Rizzo, V; Rosato, G; Spadafora, M; Sullo, P | 1 |
| Cwetsch, A; Fijałkowski, P; Wańkowicz, Z; Wierzbicki, P | 1 |
| Cross, HR | 1 |
| Kolycheva, SV; Lankin, VZ; Tikhaze, AK; Zharova, EA | 1 |
| Marzilli, M | 1 |
| Chierchia, SL | 1 |
| Dimitroula, V; Karanikis, P; Kountouris, E; Pappa, E; Pappas, K; Siogas, K; Tzimas, T | 1 |
| Saito, D | 1 |
| Buck, T; Kober, G; Sievert, H; Vallbracht, C | 1 |
| Clauser, P; Harpey, C; Maupoil, V; Rochette, L; Tabard, A | 1 |
| Adamantidis, M; Dupuis, B; Honoré, E; Libersa, C; Rouet, E | 1 |
| D'Alché, P | 1 |
| Lavanchy, N; Martin, J; Rossi, A | 3 |
| Barat, JL; Bonnet, J; Boussens, B; Bricaud, H; Brottier, L; Combe, C | 3 |
| Boucher, F; Charlon, V; Clauser, P; de Leiris, J; Favier, A; Harpey, C; Koukay, N; Mouhieddine, S | 1 |
| Boucher, F; de Leiris, J | 1 |
| Letac, B | 1 |
| Adamantidis, M; Challice, C; Dupuis, B; Honoré, E; Libersa, C; Rouet, E | 1 |
| Passeron, J | 1 |
| Brochier, M; Demange, J; Deroux, A; Ducloux, G; Monpère, C; Warin, JF | 1 |
| Schutz, DS | 1 |
| Labrid, C | 1 |
| Maridonneau-Parini, I | 1 |
| Chruściel, TL; Kozakiewicz, K; Petelenz, T | 1 |
| Brochier, M; Demange, J; Ducloux, G; Monpère, C; Warin, JF | 1 |
| Abiko, Y; Fukushi, Y; Sakai, K | 1 |
12 review(s) available for trimetazidine and Coronary Disease
| Article | Year |
|---|---|
Clinical effect of various trimetazidine formulations in chronic coronary syndrome
Topics: Angina, Stable; Chronic Disease; Coronary Disease; Humans; Randomized Controlled Trials as Topic; Treatment Outcome; Trimetazidine | 2020 |
Effect of Trimetazidine on Diabetic Patients with Coronary Heart Diseases: A Meta-Analysis of Randomized, Controlled Trials.
Topics: Blood Glucose; Coronary Disease; Diabetes Mellitus; Diastole; Exercise Tolerance; Humans; Myocardial Ischemia; Randomized Controlled Trials as Topic; Trimetazidine; Ventricular Function, Left | 2020 |
Trimetazidine reduces contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography and angioplasty: A systematic review and meta-analysis (PRISMA).
Topics: Acute Kidney Injury; Angioplasty; Contrast Media; Coronary Angiography; Coronary Disease; Glomerular Filtration Rate; Humans; Incidence; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Treatment Outcome; Trimetazidine | 2021 |
[Unsolved problems of cytoprotective therapy in patients with coronary heart disease].
Topics: Cardiotonic Agents; Cardiovascular Agents; Coronary Disease; Humans; Methylhydrazines; Trimetazidine | 2015 |
Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
Topics: Coronary Disease; Diabetes Mellitus; Fatty Acids, Nonesterified; Humans; Muscle, Skeletal; Myocardium; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 2006 |
Clinical benefits of a metabolic approach in the cardiac rehabilitation of patients with coronary artery disease.
Topics: Coronary Circulation; Coronary Disease; Humans; Myocardium; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 2006 |
Metabolic approach to myocardial ischemia: a novel therapeutic strategy for patients with coronary artery disease?
Topics: Acetanilides; Carnitine; Clinical Trials as Topic; Coenzymes; Coronary Disease; Enzyme Inhibitors; Humans; Myocardial Ischemia; Piperazines; Ranolazine; Superoxide Dismutase; Trimetazidine; Ubiquinone; Vasodilator Agents | 1995 |
Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
Topics: Angina Pectoris; Animals; Coronary Disease; Humans; Trimetazidine; Vasodilator Agents | 1999 |
Clinical benefits of a metabolic approach in the management of coronary patients.
Topics: Coronary Disease; Diabetes Complications; Drug Therapy, Combination; Humans; Myocardial Reperfusion; Trimetazidine; Ventricular Dysfunction, Left | 2000 |
Effect of coronary vasodilators on cardiac dynamics of the normal dog and the dog with experimental coronary sclerosis.
Topics: Allylamine; Animals; Coronary Angiography; Coronary Circulation; Coronary Disease; Dipyridamole; Dogs; Female; Hemodynamics; Male; Oxyfedrine; Prenylamine; Trimetazidine; Vascular Resistance; Vasodilator Agents | 1976 |
Ischemic myocardial cell necrosis: calcium overload or oxygen free-radicals?
Topics: Calcium; Cardiomyopathies; Coronary Disease; Free Radicals; Humans; Myocardial Reperfusion; Necrosis; Oxygen; Time Factors; Trimetazidine | 1990 |
[The action of trimetazidine (TMZ)].
Topics: Coronary Disease; Energy Metabolism; Humans; Myocardium; Piperazines; Trimetazidine | 1987 |
22 trial(s) available for trimetazidine and Coronary Disease
| Article | Year |
|---|---|
Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study
Topics: Acute Kidney Injury; Aged; Animals; Antioxidants; Cardiac Catheterization; Contrast Media; Coronary Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Trimetazidine; Ubiquinone | 2018 |
Effect of trimetazidine on recurrent angina pectoris and left ventricular structure in elderly multivessel coronary heart disease patients with diabetes mellitus after drug-eluting stent implantation: a single-centre, prospective, randomized, double-blind
Topics: Aged; Aged, 80 and over; Angina Pectoris; Coronary Disease; Diabetes Complications; Double-Blind Method; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Secondary Prevention; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 2014 |
[Clinicopathogenetic features of coronary heart disease combined with chronic obstructive pulmonary diseases and efficiency of therapy with trimetazidin].
Topics: Coronary Disease; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Trimetazidine; Vascular Resistance; Vasodilator Agents | 2008 |
Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
Topics: Aged; Cardiomyopathy, Dilated; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Follow-Up Studies; Humans; Male; Myocardial Ischemia; Quality of Life; Severity of Illness Index; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2009 |
[Therapeutic value of trimetazidine in patients with coronary heart disease and left ventricular dysfunction].
Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Female; Humans; Male; Middle Aged; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2005 |
The effects of trimetazidine on heart rate variability in patients with slow coronary artery flow.
Topics: Blood Flow Velocity; Chi-Square Distribution; Coronary Angiography; Coronary Disease; Coronary Vessels; Double-Blind Method; Electrocardiography, Ambulatory; Endothelin-1; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Nitric Oxide; Regional Blood Flow; Statistics, Nonparametric; Trimetazidine; Vasodilator Agents | 2006 |
Combination therapy of trimetazidine with diltiazem in patients with coronary artery disease. Group of South of France Investigators.
Topics: Administration, Oral; Angina Pectoris; Coronary Disease; Diltiazem; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Exercise Test; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome; Trimetazidine | 1995 |
Myocardial cytoprotection during percutaneous transluminal coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Myocardial Ischemia; Reproducibility of Results; Trimetazidine | 1993 |
Effects of trimetazidine on heart rate variability and left ventricular systolic performance in patients with coronary artery disease after percutaneous transluminal angioplasty.
Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Echocardiography; Echocardiography, Doppler; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Reperfusion Injury; Signal Processing, Computer-Assisted; Time Factors; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 1997 |
Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease.
Topics: Administration, Oral; Coronary Disease; Cross-Over Studies; Dobutamine; Drug Administration Schedule; Echocardiography; Female; Humans; Male; Middle Aged; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 1998 |
Lack of effects of trimetazidine on systemic hemodynamics in patients with coronary artery disease: a placebo-controlled study.
Topics: Angina Pectoris; Aorta; Blood Pressure; Cardiac Output; Coronary Disease; Double-Blind Method; Exercise Tolerance; Female; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Placebos; Pulmonary Wedge Pressure; Trimetazidine; Vascular Resistance; Ventricular Function, Left; Ventricular Pressure | 1994 |
Effect of trimetazidine on 99Tcm-tetrofosmin uptake in patients with coronary artery disease.
Topics: Aged; Coronary Disease; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Trimetazidine; Ultrasonography; Vasodilator Agents | 2000 |
Trimetazidine as indirect antioxidant.
Topics: Angina Pectoris; Antioxidants; Coronary Disease; Erythrocytes; Glutathione Peroxidase; Humans; Lipid Peroxidation; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Superoxide Dismutase; Trimetazidine; Vasodilator Agents | 2000 |
Dobutamine stress echocardiography and the effects of trimetazidine on left ventricular dysfunction in patients with coronary artery disease.
Topics: Aged; Cardiotonic Agents; Coronary Disease; Cross-Over Studies; Dobutamine; Double-Blind Method; Exercise Test; Female; Humans; Male; Middle Aged; Trimetazidine; Ultrasonography; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function, Left | 2001 |
Metabolic management of coronary heart disease: adjunctive treatment with trimetazidine decreases QT dispersion in patients with a first acute myocardial infarction.
Topics: Aged; Arrhythmias, Cardiac; Coronary Disease; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Trimetazidine; Vasodilator Agents | 2001 |
Myocardial protection during percutaneous transluminal coronary angioplasty: effects of trimetazidine.
Topics: Angioplasty, Balloon, Coronary; Coronary Circulation; Coronary Disease; Electrocardiography; Female; Hemodynamics; Humans; Injections, Intra-Arterial; Male; Middle Aged; Trimetazidine | 1992 |
Cardioprotective effect of trimetazidine in severe ischemic cardiomyopathy.
Topics: Cardiomyopathy, Dilated; Coronary Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Stroke Volume; Trimetazidine | 1990 |
Therapeutic value of a cardioprotective agent in patients with severe ischaemic cardiomyopathy.
Topics: Angina Pectoris; Cardiomyopathies; Coronary Disease; Double-Blind Method; Drug Evaluation; Female; Hemodynamics; Humans; Male; Middle Aged; Piperazines; Trimetazidine | 1990 |
[Value of trimetazidine in the long-term treatment of cardiomyopathies of ischemic origin].
Topics: Analysis of Variance; Cardiac Volume; Coronary Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Placebos; Stroke Volume; Trimetazidine | 1989 |
[Effectiveness of trimetazidine in stable effort angina due to chronic coronary insufficiency. A double-blind versus placebo study].
Topics: Angina Pectoris; Chronic Disease; Coronary Disease; Double-Blind Method; Exercise Test; Humans; Male; Piperazines; Trimetazidine | 1986 |
[Therapeutic value of a combination of trimetazidine with a calcium inhibitor in the treatment of chronic coronary insufficiency].
Topics: Chronic Disease; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Heart; Humans; Male; Nifedipine; Piperazines; Trimetazidine | 1986 |
[Value of the combination of trimetazidine and a calcium inhibitor in the treatment of chronic coronary insufficiency. Double-blind controlled study versus placebo].
Topics: Calcium Channel Blockers; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Piperazines; Trimetazidine | 1986 |
27 other study(ies) available for trimetazidine and Coronary Disease
| Article | Year |
|---|---|
Clinical Implications of Nicorandil Combined with Trimetazidine in Patients with Coronary Heart Disease: A Real-World Observational Study.
Topics: Adult; Angina Pectoris; Coronary Disease; Humans; Nicorandil; Retrospective Studies; Trimetazidine | 2022 |
Trimetazidine Effect on the Cardiac Autonomic Nerve System after Percutaneous Coronary Intervention in Coronary Heart Disease: A Propensity-score Matched Study.
Topics: Autonomic Nervous System; Autonomic Pathways; Coronary Disease; Heart Rate; Humans; Percutaneous Coronary Intervention; Trimetazidine | 2022 |
Observation of Curative Effect of Trimetazidine Combined with Metoprolol in Elderly Patients with Coronary Heart Disease Complicated with Heart Failure and the Effect of Myocardial Remodeling by Integrated Traditional Chinese and Western Medicine.
Topics: Aged; Cardiovascular Diseases; China; Coronary Disease; Glucose; Heart Failure; Humans; Metoprolol; Middle Aged; Trimetazidine | 2022 |
The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease.
Topics: Aged; Angina Pectoris; Coronary Angiography; Coronary Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Exercise Test; Exercise Tolerance; Female; Follow-Up Studies; Humans; Male; Middle Aged; Probability; Prospective Studies; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Time Factors; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2008 |
[A prospective study on trimetazidine effectiveness and tolerability in diabetic patients in association to the previous treatment of their coronary disease. DIETRIC study].
Topics: Adult; Aged; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; Prospective Studies; Trimetazidine; Vasodilator Agents | 2005 |
Evaluation of the effect of trimetazidine on Tc-99m methoxyisobutyl isonitrile gated scintigraphy in patients with coronary artery ectasia.
Topics: Adult; Age Factors; Aged; Cohort Studies; Coronary Disease; Dilatation, Pathologic; Female; Heart Function Tests; Humans; Male; Middle Aged; Prognosis; Risk Assessment; Severity of Illness Index; Sex Factors; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Trimetazidine; Ventricular Function, Left | 2005 |
Suppression of angioplasty-related inflammation by pre-procedural treatment with trimetazidine.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; Coronary Disease; Female; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitrates; Nitrites; Reactive Oxygen Species; Time Factors; Treatment Outcome; Trimetazidine; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2006 |
Metabolic agents in the management of diabetic coronary patients: a new era.
Topics: Carnitine; Coronary Disease; Diabetes Mellitus; Diabetic Angiopathies; Dichloroacetic Acid; Enzyme Inhibitors; Epoxy Compounds; Humans; Perhexiline; Trimetazidine; Vasodilator Agents; Vitamin B Complex | 2008 |
Metabolic agents in the management of diabetic coronary patients: a new era.
Topics: Acetanilides; Citric Acid Cycle; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dichloroacetic Acid; Enzyme Inhibitors; Epoxy Compounds; Humans; Insulin Resistance; Perhexiline; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 2008 |
Coronary artery constriction in rats: necrotic and apoptotic myocyte death.
Topics: Animals; Apoptosis; Coronary Disease; DNA; DNA Nucleotidylexotransferase; Electrophoresis, Agar Gel; Follow-Up Studies; Heart Septum; Heart Ventricles; Microscopy, Confocal; Myocardium; Myosins; Necrosis; Rats; Trimetazidine; Vasodilator Agents | 1998 |
[Trimetazidine effects on exercise tolerance and left ventricular diastolic function in patients with coronary heart disease].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Coronary Disease; Diastole; Dipyridamole; Drug Therapy, Combination; Echocardiography; Electrocardiography; Exercise Tolerance; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitrates; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 1999 |
[Influence of trimetazidine on echocardiography parameters and free radical stress index in coronary artery disease and end-stage renal failure patients treated by hemodialysis: preliminary communication].
Topics: Coronary Disease; Echocardiography; Female; Free Radicals; Humans; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Trimetazidine; Vasodilator Agents | 1999 |
Trimetazidine: a novel protective role via maintenance of Na(+)/K(+)-ATPase activity?
Topics: Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Fatty Acids; Glucose; Humans; Myocardial Ischemia; Myocardium; Oxygen Consumption; Premedication; Sodium; Sodium-Potassium-Exchanging ATPase; Trimetazidine; Vasodilator Agents | 2000 |
Evolution of free radical formation during low-flow ischemia and reperfusion in isolated rat heart.
Topics: Animals; Coronary Disease; Electron Spin Resonance Spectroscopy; Free Radicals; In Vitro Techniques; Lipid Peroxidation; Male; Myocardial Reperfusion Injury; Rats; Rats, Inbred Strains; Trimetazidine | 1990 |
Antiischemic effect of trimetazidine: enzymatic and electric response in a model of in-vitro myocardial ischemia.
Topics: Animals; Cell Survival; Coronary Disease; Creatine Kinase; Diltiazem; Glyoxylates; Guinea Pigs; In Vitro Techniques; Pyridoxine; Trimetazidine; Verapamil | 1990 |
Electrocardiographic assessment of trimetazidine antiischemic properties.
Topics: Action Potentials; Animals; Computers; Coronary Disease; Disease Models, Animal; Electrocardiography; Female; Male; Monitoring, Physiologic; Rabbits; Trimetazidine | 1990 |
Antiischemic effects of trimetazidine: 31P-NMR spectroscopy study in the isolated rat heart.
Topics: Animals; Coronary Disease; Disease Models, Animal; Female; In Vitro Techniques; Magnetic Resonance Spectroscopy; Myocardial Reperfusion Injury; Phosphorus; Rats; Rats, Inbred Strains; Trimetazidine | 1990 |
Effect of a 5 day trimetazidine pretreatment in a model of ischemic and reperfused isolated rat heart: spin trapping experiments.
Topics: Animals; Coronary Disease; Dimethyl Sulfoxide; Electron Spin Resonance Spectroscopy; Freeze Drying; Glutathione; Glutathione Reductase; Glutathione Transferase; In Vitro Techniques; Myocardial Reperfusion Injury; Nitrogen Oxides; Rats; Rats, Inbred Strains; Superoxide Dismutase; Trimetazidine | 1990 |
[Coronary insufficiency. In favor of a direct action on the ischemic cell].
Topics: Coronary Disease; Energy Metabolism; Humans; Piperazines; Trimetazidine | 1986 |
[Trimetazidine and ischemic heart disease. 3d international symposium].
Topics: Coronary Disease; Humans; Piperazines; Trimetazidine | 1986 |
[Trimetazidine preservation of the energy potential of the myocardium during ischemia and reperfusion. Phosphorus NMR spectroscopy study of the isolated heart].
Topics: Adenosine Triphosphate; Animals; Coronary Circulation; Coronary Disease; Female; Hydrogen-Ion Concentration; In Vitro Techniques; Magnetic Resonance Spectroscopy; Phosphocreatine; Phosphorylation; Piperazines; Rats; Rats, Inbred Strains; Trimetazidine | 1986 |
[Effects of trimetazidine on a model of in vitro myocardial ischemia].
Topics: Animals; Coronary Circulation; Coronary Disease; Creatine Kinase; Diltiazem; Electrocardiography; Guinea Pigs; Heart; In Vitro Techniques; Piperazines; Trimetazidine; Verapamil | 1986 |
[Therapeutic importance of trimetazidine in ischemic pathology of the myocardium].
Topics: Coronary Disease; Drug Therapy, Combination; Humans; Piperazines; Trimetazidine | 1986 |
[Cellular disorders induced by ischemia. The effect of trimetazidine].
Topics: Cell Membrane Permeability; Coronary Disease; Energy Metabolism; Free Radicals; Humans; Myocardium; Oxygen Consumption; Piperazines; Superoxides; Trimetazidine | 1986 |
[Effect of trimetazidine on membrane changes induced by oxygen free radicals in human red cells].
Topics: Cell Membrane Permeability; Coronary Disease; Erythrocyte Membrane; Humans; Piperazines; Superoxides; Trimetazidine | 1986 |
Anti-ischemic effects of trimetazidine: 31P-NMR spectroscopy in the isolated rat heart.
Topics: Adenosine Triphosphate; Animals; Coronary Disease; Energy Metabolism; Female; Magnetic Resonance Spectroscopy; Myocardium; Phosphates; Phosphocreatine; Phosphorylation; Piperazines; Rats; Rats, Inbred Strains; Trimetazidine | 1987 |
Inhibitory effect of trimetazidine on utilization of myocardial glycogen during coronary ligation in dogs.
Topics: Animals; Blood Pressure; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Female; Glycogen; Heart Rate; Ligation; Male; Myocardium; Phosphorylases; Piperazines; Trimetazidine | 1986 |